These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32562907)

  • 1. Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm.
    Domurath B; Kurze I; Kirschner-Hermanns R; Kaufmann A; Feneberg W; Schmidt P; Henze T; Flachenecker P; Brandt A; Vance WN; Beck J; Vonthien M; Ratering K;
    Mult Scler Relat Disord; 2020 Sep; 44():102248. PubMed ID: 32562907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].
    Domurath B; Flachenecker P; Henze T; Feneberg W; Brandt A; Kurze I; Kirschner-Hermanns R; Kaufmann A; Bremer J; Vonthien M; Ratering K; Schäfer C; Vance WN; Schmidt P
    Nervenarzt; 2021 Apr; 92(4):349-358. PubMed ID: 33399923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis.
    Beck J; Jaekel AK; Zeller FL; Kowollik M; Kurze I; Kaufmann A; Feneberg W; Brandt A; Flachenecker P; Henze T; Domurath B; Schmidt P; Vance WN; Goldschmidt F; Kirschner-Hermanns RKM; Knüpfer SC
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis.
    Jaekel AK; Winterhagen FI; Zeller FL; Butscher AL; Knappe FK; Schmitz F; Hauk C; Stein J; Kirschner-Hermanns RKM; Knüpfer SC
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
    De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and urodynamic risk factors of recurrent urinary tract infections in patients with multiple sclerosis.].
    Salinas-Casado J; Vírseda-Chamorro M; Méndez-Rubio S; López-Pérez E; Esteban-Fuertes M; Moreno-Sierra J; Guiu-Antem M; Pytel V; Montero-Escribano P; Matías-Guiu Guía J
    Arch Esp Urol; 2019 Dec; 72(10):1010-1017. PubMed ID: 31823849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuro-urological diagnostics and treatment of non-traumatic/degenerative neurogenic lower urinary tract dysfunction exemplified by multiple sclerosis].
    Kurze I; Jaekel AK
    Aktuelle Urol; 2024 Aug; 55(4):315-325. PubMed ID: 38653466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
    Dray E; Cameron AP; Clemens JQ; Qin Y; Covalschi D; Stoffel J
    J Urol; 2018 Oct; 200(4):868-874. PubMed ID: 29702098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower urinary tract dysfunction in patients with multiple sclerosis: A post-void residual analysis of 501 cases.
    Monti Bragadin M; Motta R; Messmer Uccelli M; Tacchino A; Ponzio M; Podda J; Konrad G; Rinaldi S; Della Cava M; Battaglia MA; Brichetto G
    Mult Scler Relat Disord; 2020 Oct; 45():102378. PubMed ID: 32683303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.
    Ineichen BV; Schneider MP; Hlavica M; Hagenbuch N; Linnebank M; Kessler TM
    Mult Scler; 2018 Apr; 24(4):529-534. PubMed ID: 28367674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UK consensus on the management of the bladder in multiple sclerosis.
    Fowler CJ; Panicker JN; Drake M; Harris C; Harrison SC; Kirby M; Lucas M; Macleod N; Mangnall J; North A; Porter B; Reid S; Russell N; Watkiss K; Wells M
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):470-7. PubMed ID: 19372287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A UK consensus on the management of the bladder in multiple sclerosis.
    Fowler CJ; Panicker JN; Drake M; Harris C; Harrison SC; Kirby M; Lucas M; Macleod N; Mangnall J; North A; Porter B; Reid S; Russell N; Watkiss K; Wells M
    Postgrad Med J; 2009 Oct; 85(1008):552-9. PubMed ID: 19789195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of overactive bladder influenced by methods of clinical assessment--micturition diary vs. urodynamics].
    Skorupski P; Tomaszewski J; Adamiak A; Jankiewicz K; Rechberger T
    Ginekol Pol; 2003 Sep; 74(9):1018-22. PubMed ID: 14674162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis?
    Gravina GL; Costa AM; Galatioto GP; Ronchi P; Tubaro A; Vicentini C
    J Urol; 2007 Sep; 178(3 Pt 1):959-63; discussion 963-4. PubMed ID: 17632142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the best practice policy statement on urodynamic antibiotic prophylaxis for the high-risk patient in the era of antibiotic stewardship.
    Fox C; Kim MJ; Kuo YH; Fromer DL
    Neurourol Urodyn; 2020 Nov; 39(8):2246-2252. PubMed ID: 32761979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].
    Hermieu JF;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.
    Akkoç Y; Ersöz M; Yüceyar N; Tunç H; Köklü K; Yoldaş TK; Dönmez Ü; Uzunköprü C; Alemdaroğlu E; Bilen Ş; Emre U; Özdolap Ş; Tuncay E; Yücesan C; Gök H; Ercan MB; Uygunol K; Koçer B; Zinnuroğlu M;
    J Spinal Cord Med; 2016; 39(2):229-33. PubMed ID: 25936385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
    Amarenco G; Chartier-Kastler E; Denys P; Jean JL; de Sèze M; Lubetzski C
    Mult Scler; 2013 Dec; 19(14):1931-7. PubMed ID: 23698129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.